Risk: benefit ratio is important in treating atopic dermatitis
- PMID: 12399360
- PMCID: PMC1124459
- DOI: 10.1136/bmj.325.7370.970
Risk: benefit ratio is important in treating atopic dermatitis
Comment on
-
New treatments for atopic dermatitis.BMJ. 2002 Jun 29;324(7353):1533-4. doi: 10.1136/bmj.324.7353.1533. BMJ. 2002. PMID: 12089073 Free PMC article. No abstract available.
References
-
- Charman CR, Morris AD, Williams HC. Topical corticosteroid phobia in patients with atopic eczema. Br J Derm. 2000;142:931–936. - PubMed
-
- Murch SH. Toll of allergy reduced by probiotics. Lancet. 2001;357:1057–1058. - PubMed
-
- Wahn U, Bos JD, Goodfield M, Caputo R, Papp K, Manjra A, et al. Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children. Pediatrics. 2002;110:1–8. - PubMed
-
- Kang S, Lucky AW, Pariser D, Lawrence I, Hanifin JM. Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children. J Am Acad Dermatol. 2001;44(suppl 1):S58–S64. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources